Bio and generic demand driving increased internationalisation and renewed optimism amongst industry The Japanese pharma market is expected to grow quickly in 2019 following the release of a new report published ahead ofCPhI Japan 2019. The trade exhibition (18-20 March, 2019) will open its
More
Nuremberg, April 15th 2020 – Bio-Gate AG (ISIN DE000BGAG981), one of the leading providers of innovative technologies and solutions for
More
Leading Australian CRO Avance Clinical said there was still strong demand from Asian and US sponsors, and commended Australian sites
More
Sectors such as the pharmaceutical, cosmetics and food industries in particular rely on blisters for packaging their sensitive products. With
More
London – Arena International announced today that the Temperature Controlled Logistics in Biopharmaceuticals Conference will be held as a Virtual
More
Two BIOCAD products, Acellbia (INN: rituximab) and Herticad (INN: trastuzumab), received the first European registration certificate in Bosnia and Herzegovina.
More
Australian CRO Avance Clinical said that Australia’s fast regulatory approval environment, key opinion leader expertise and high-quality clinical research sites,
More
Global guidance for pharmacists in community, hospital and clinical biology on coronavirus/COVID-19 has been updated by the International Pharmaceutical Federation
More
Biotechnological company BIOCAD has announced the research in order to create an mRNA vaccine against SARS-COV-2 (coronavirus). Development will be
More
EA Pharma Co., Ltd. and its parent company Eisai Co., Ltd. announced that Japan’s Ministry of Health, Labour and Welfare
More
NanoViricides, Inc. (NYSE American: NNVC) (the “Company”) a leader in the development of highly effective antiviral therapies based on a
More